<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36547779</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>21</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1590-3478</ISSN><JournalIssue CitedMedium="Internet"><Volume>44</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology</Title><ISOAbbreviation>Neurol Sci</ISOAbbreviation></Journal><ArticleTitle>Clinimetrics of the cognitive section of the Italian ALS Cognitive Behavioral Screen (ALS-CBS&#x2122;).</ArticleTitle><Pagination><StartPage>1243</StartPage><EndPage>1249</EndPage><MedlinePgn>1243-1249</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10072-022-06569-9</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The present study aimed at (1) providing further validity and reliability evidence for the Italian version of the cognitive section of the ALS Cognitive Behavioral Screen (ALS-CBS&#x2122;) and (2) testing its diagnostics within an Italian ALS cohort, as well as at (3) exploring its capability to discriminate patients from healthy controls (HCs).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">N&#x2009;=&#x2009;293 non-demented ALS patients were administered the cognitive sections of the ALS-CBS&#x2122; and Edinburgh Cognitive and Behavioural ALS Screen (ECAS). N&#x2009;=&#x2009;96 HCs demographically matched with N&#x2009;=&#x2009;96 patients were also administered the cognitive section of the ALS-CBS&#x2122;. In patients, factorial and construct validity, internal reliability, and diagnostics against a defective score on the cognitive section of the ECAS were tested. Case-control discrimination was assessed via a logistic regression.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">ALS-CBS&#x2122; cognitive subscales were underpinned by a simple, unidimensional structure, internally reliable (McDonald's &#x3c9;&#x2009;=&#x2009;0.74), and mostly related with ECAS executive and fluency scores (r<sub>s</sub>&#x2009;=&#x2009;0.54-0.71). Both raw and age- and education-adjusted scores on the cognitive section of the ALS-CBS&#x2122; accurately detected ECAS-defined cognitive impairment (AUC&#x2009;=&#x2009;0.80 and .88, respectively), yielding optimal error-based, information-based and unitary diagnostics. A cut-off of&#x2009;&lt;&#x2009;15.374 was identified on adjusted scores. The test was able to discriminate patients from HCs (p&#x2009;&lt;&#x2009;0.001).</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="CONCLUSIONS">The cognitive section of the Italian ALS-CBS&#x2122; is a valid, reliable, and diagnostically sound ALS-specific screener for detecting frontotemporal, executive-/attentive-based cognitive inefficiency in non-demented ALS patients, being also able to discriminate them from normotypical individuals.</AbstractText><CopyrightInformation>&#xa9; 2022. Fondazione Societ&#xe0; Italiana di Neurologia.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Aiello</LastName><ForeName>Edoardo Nicol&#xf2;</ForeName><Initials>EN</Initials><AffiliationInfo><Affiliation>Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Piazzale Brescia 20, 20149, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>PhD Program in Neuroscience, School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Greco</LastName><ForeName>Lucia Catherine</ForeName><Initials>LC</Initials><AffiliationInfo><Affiliation>Neuromuscular Omnicentre (NEMO), Fondazione Serena Onlus, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NeMO Lab, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>La Tona</LastName><ForeName>Antonino</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Human and Social Sciences, University of Bergamo, Bergamo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Solca</LastName><ForeName>Federica</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Piazzale Brescia 20, 20149, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Torre</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Piazzale Brescia 20, 20149, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carelli</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Piazzale Brescia 20, 20149, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pain</LastName><ForeName>Debora</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Istituti Clinici Scientifici Maugeri IRCCS, Neurorehabilitation Department of Milan Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Radici</LastName><ForeName>Alice</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Istituti Clinici Scientifici Maugeri IRCCS, Neurorehabilitation Department of Milan Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lizio</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Neuromuscular Omnicentre (NEMO), Fondazione Serena Onlus, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Casiraghi</LastName><ForeName>Jacopo</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Neuromuscular Omnicentre (NEMO), Fondazione Serena Onlus, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cerri</LastName><ForeName>Federica</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Neuromuscular Omnicentre (NEMO), Fondazione Serena Onlus, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brugnera</LastName><ForeName>Agostino</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Human and Social Sciences, University of Bergamo, Bergamo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Compare</LastName><ForeName>Angelo</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Human and Social Sciences, University of Bergamo, Bergamo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Woolley</LastName><ForeName>Susan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Syneos Health, Morrisville, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murphy</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Biogen, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tremolizzo</LastName><ForeName>Lucio</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Appollonio</LastName><ForeName>Ildebrando</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verde</LastName><ForeName>Federico</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Piazzale Brescia 20, 20149, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathophysiology and Transplantation, Dino Ferrari Center", Universit&#xe0; degli Studi di Milano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silani</LastName><ForeName>Vincenzo</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Piazzale Brescia 20, 20149, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathophysiology and Transplantation, Dino Ferrari Center", Universit&#xe0; degli Studi di Milano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ticozzi</LastName><ForeName>Nicola</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Piazzale Brescia 20, 20149, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathophysiology and Transplantation, Dino Ferrari Center", Universit&#xe0; degli Studi di Milano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lunetta</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Istituti Clinici Scientifici Maugeri IRCCS, Neurorehabilitation Department of Milan Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Sansone</LastName><ForeName>Valeria Ada</ForeName><Initials>VA</Initials><AffiliationInfo><Affiliation>PhD Program in Neuroscience, School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Sciences of Health, University of Milan, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Poletti</LastName><ForeName>Barbara</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0003-4398-2051</Identifier><AffiliationInfo><Affiliation>Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Piazzale Brescia 20, 20149, Milan, Italy. b.poletti@auxologico.it.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Neurol Sci</MedlineTA><NlmUniqueID>100959175</NlmUniqueID><ISSNLinking>1590-1874</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003072" MajorTopicYN="Y">Cognition Disorders</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009483" MajorTopicYN="N">Neuropsychological Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060825" MajorTopicYN="Y">Cognitive Dysfunction</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007558" MajorTopicYN="N" Type="Geographic">Italy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003071" MajorTopicYN="N">Cognition</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS Cognitive Behavioral Screen</Keyword><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Clinimetrics</Keyword><Keyword MajorTopicYN="N">Cognitive screening</Keyword><Keyword MajorTopicYN="N">Frontotemporal degeneration</Keyword><Keyword MajorTopicYN="N">Neuropsychology</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>22</Day><Hour>11</Hour><Minute>19</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36547779</ArticleId><ArticleId IdType="doi">10.1007/s10072-022-06569-9</ArticleId><ArticleId IdType="pii">10.1007/s10072-022-06569-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Strong MJ, Abrahams S, Goldstein LH, Woolley S, Mclaughlin P, Snowden J, Turner MR (2017) Amyotrophic lateral sclerosis-frontotemporal spectrum disorder (ALS-FTSD): revised diagnostic criteria. Amyotroph Lateral Scler Frontotemporal Degener 18:153&#x2013;174</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2016.1267768</ArticleId><ArticleId IdType="pubmed">28054827</ArticleId><ArticleId IdType="pmc">7409990</ArticleId></ArticleIdList></Reference><Reference><Citation>Huynh W, Ahmed R, Mahoney CJ, Nguyen C, Tu S, Caga J, Kiernan MC (2020) The impact of cognitive and behavioral impairment in amyotrophic lateral sclerosis. Expert Rev Neurother 20:281&#x2013;293</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14737175.2020.1727740</ArticleId><ArticleId IdType="pubmed">32031423</ArticleId></ArticleIdList></Reference><Reference><Citation>Gray D, Abrahams S (2022) International evaluation of current practices in cognitive assessment for motor neurone disease. Br J Neurosci Nurs 18:38&#x2013;44</Citation><ArticleIdList><ArticleId IdType="doi">10.12968/bjnn.2022.18.1.38</ArticleId></ArticleIdList></Reference><Reference><Citation>Beswick E, Park E, Wong C, Mehta AR, Dakin R, Chandran S, Pal S (2021) A systematic review of neuropsychiatric and cognitive assessments used in clinical trials for amyotrophic lateral sclerosis. J Neurol 268:4510&#x2013;4521</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-020-10203-z</ArticleId><ArticleId IdType="pubmed">32910255</ArticleId></ArticleIdList></Reference><Reference><Citation>Woolley SC, York MK, Moore DH, Strutt AM, Murphy J, Schulz PE, Katz JS (2010) Detecting frontotemporal dysfunction in ALS: utility of the ALS Cognitive Behavioral Screen (ALS-CBS&#x2122;). Amyotroph Lateral Scler 11:303&#x2013;311</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482961003727954</ArticleId><ArticleId IdType="pubmed">20433413</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrahams S, Newton J, Niven E, Foley J, Bak TH (2014) Screening for cognition and behaviour changes in ALS. Amyotroph Lateral Scler Frontotemporal Degener 15:9&#x2013;14</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2013.805784</ArticleId><ArticleId IdType="pubmed">23781974</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon N, Goldstein LH (2019) Screening for cognitive and behavioral change in amyotrophic lateral sclerosis/motor neuron disease: a systematic review of validated screening methods. Amyotroph Lateral Scler Frontotemporal Degener 20:1&#x2013;11</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2018.1530264</ArticleId><ArticleId IdType="pubmed">30585510</ArticleId></ArticleIdList></Reference><Reference><Citation>Gosselt IK, Nijboer TC, Van Es MA (2020) An overview of screening instruments for cognition and behavior in patients with ALS: selecting the appropriate tool for clinical practice. Amyotroph Lateral Scler Frontotemporal Degener 21:324&#x2013;336</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2020.1732424</ArticleId><ArticleId IdType="pubmed">32157912</ArticleId></ArticleIdList></Reference><Reference><Citation>Taule T, S&#xf8;vik M, Lein RK, Wehling E, A&#xdf;mus J, Rekand T (2020) Psychometric properties of cognitive assessment in amyotrophic lateral sclerosis: a systematic review. Patient Relat Outcome Measures 11:181</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/PROM.S256828</ArticleId></ArticleIdList></Reference><Reference><Citation>Poletti B, Solca F, Carelli L, Madotto F, Lafronza A, Faini A, Silani V (2016) The validation of the Italian Edinburgh cognitive and behavioural ALS screen (ECAS). Amyotroph Lateral Scler Frontotemporal Degener 17:489&#x2013;498</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2016.1183679</ArticleId><ArticleId IdType="pubmed">27219526</ArticleId></ArticleIdList></Reference><Reference><Citation>Tremolizzo L, Lizio A, Santangelo G, Diamanti S, Lunetta C, Gerardi F, Appollonio I (2020) ALS Cognitive Behavioral Screen (ALS-CBS): normative values for the Italian population and clinical usability. Neurol Sci 41:835&#x2013;841</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-019-04154-1</ArticleId><ArticleId IdType="pubmed">31807998</ArticleId></ArticleIdList></Reference><Reference><Citation>Siciliano M, Trojano L, Trojsi F, Greco R, Santoro M, Basile G, Santangelo G (2017) Edinburgh Cognitive and Behavioural ALS Screen (ECAS)-Italian version: regression based norms and equivalent scores. Neurol Sci 38:1059&#x2013;1068</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-017-2919-4</ArticleId><ArticleId IdType="pubmed">28332040</ArticleId></ArticleIdList></Reference><Reference><Citation>Poletti B, Solca F, Carelli L, Faini A, Madotto F, Lafronza A, Silani V (2018) Cognitive-behavioral longitudinal assessment in ALS: the Italian Edinburgh Cognitive and Behavioral ALS screen (ECAS). Amyotroph Lateral Scler Frontotemporal Degener 19:387&#x2013;395</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2018.1473443</ArticleId><ArticleId IdType="pubmed">29804470</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiello EN, Iazzolino B, Pain D, Peotta L, Palumbo F, Radici A, Chi&#xf2; A (2022) The diagnostic value of the Italian version of the Edinburgh Cognitive and Behavioral ALS Screen (ECAS). Amyotroph Lateral Scler Frontotemporal Degener 1&#x2013;5.</Citation></Reference><Reference><Citation>Aiello EN, Solca F, Torre S, Carelli L, Monti A, Ferrucci R, Poletti B (2022) Reliable change indices for the Italian Edinburgh Cognitive and Behavioural ALS Screen (ECAS). Amyotroph Lateral Scler Frontotemporal Degener 1&#x2013;5.</Citation></Reference><Reference><Citation>Greco LC, Lizio A, Casiraghi J, Sansone VA, Tremolizzo L, Riva N, Lunetta C (2022) A preliminary comparison between ECAS and ALS-CBS in classifying cognitive&#x2013;behavioural phenotypes in a cohort of non-demented amyotrophic lateral sclerosis patients. J Neurol 269:1899&#x2013;1904</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10753-w</ArticleId><ArticleId IdType="pubmed">34410493</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiello EN, Rimoldi S, Bolognini N, Appollonio IM, Arcara G (2022) Psychometrics and diagnostics of Italian cognitive screening test: a systematic review. Neurol Sci 43:821&#x2013;845</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-021-05683-4</ArticleId><ArticleId IdType="pubmed">34816316</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, Munsat TL (2000) El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 1:293&#x2013;299</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Rascovsky K, Hodges JR, Knopman D, Mendez MF, Kramer JH, Neuhaus J, Miller BL (2011) Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 134:2456&#x2013;2477</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr179</ArticleId><ArticleId IdType="pubmed">21810890</ArticleId><ArticleId IdType="pmc">3170532</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorno-Tempini ML, Hillis AE, Weintraub S, Kertesz A, Mendez M, Cappa SF, Grossman M (2011) Classification of primary progressive aphasia and its variants. Neurology 76:1006&#x2013;1014</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e31821103e6</ArticleId><ArticleId IdType="pubmed">21325651</ArticleId><ArticleId IdType="pmc">3059138</ArticleId></ArticleIdList></Reference><Reference><Citation>Poletti B, Aiello EN, Solca F, Torre S, Carelli L, Ferrucci R, Silani V (2022) Diagnostic properties of the Italian ECAS Carer Interview (ECAS-CI). Neurol Sci 1&#x2013;6.</Citation></Reference><Reference><Citation>Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, the BDNF Study Group (1999) The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. J Neurol Sci 169:13&#x2013;21</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(99)00210-5</ArticleId><ArticleId IdType="pubmed">10540002</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimura F, Fujimura C, Ishida S, Nakajima H, Furutama D, Uehara H, Hanafusa T (2006) Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS. Neurology 66:265&#x2013;267</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000194316.91908.8a</ArticleId><ArticleId IdType="pubmed">16434671</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HY (2013) Statistical notes for clinical researchers: assessing normal distribution (2) using skewness and kurtosis. Restor Dent Endod 38:52&#x2013;54</Citation><ArticleIdList><ArticleId IdType="doi">10.5395/rde.2013.38.1.52</ArticleId><ArticleId IdType="pubmed">23495371</ArticleId><ArticleId IdType="pmc">3591587</ArticleId></ArticleIdList></Reference><Reference><Citation>Hobart JC, Cano SJ, Warner TT, Thompson AJ (2012) What sample sizes for reliability and validity studies in neurology? J Neurol 259:2681&#x2013;2694</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-012-6570-y</ArticleId><ArticleId IdType="pubmed">22729386</ArticleId></ArticleIdList></Reference><Reference><Citation>Kyriazos TA (2018) Applied psychometrics: sample size and sample power considerations in factor analysis (EFA, CFA) and SEM in general. Psychology 9:2207</Citation><ArticleIdList><ArticleId IdType="doi">10.4236/psych.2018.98126</ArticleId></ArticleIdList></Reference><Reference><Citation>Larner AJ (2019) New unitary metrics for dementia test accuracy studies. Prog Neurol Psychiatry 23:21&#x2013;25</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pnp.543</ArticleId></ArticleIdList></Reference><Reference><Citation>Goksuluk D, Korkmaz S, Zararsiz G, Karaagaoglu AE (2016) easyROC: an interactive web-tool for ROC curve analysis using R language environment. The R Journal 8:213&#x2013;230</Citation><ArticleIdList><ArticleId IdType="doi">10.32614/RJ-2016-042</ArticleId></ArticleIdList></Reference><Reference><Citation>Bossuyt PM (2010) Clinical validity: defining biomarker performance. Scand J Clin Lab Invest 70:46&#x2013;52</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/00365513.2010.493383</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiello EN, Esposito A, Giannone I, Diana L, Woolley S, Murphy J, ..., Appollonio I (2022d) ALS Cognitive Behavioral Screen-Phone Version (ALS-CBS&#x2122;-PhV): norms, psychometrics, and diagnostics in an Italian population sample. Neurol Sci 43:2571-2578.</Citation></Reference><Reference><Citation>Cohen J (1988) Statistical power analysis for the behavioral sciences. Erlbaum</Citation></Reference><Reference><Citation>McMillan CT, Wuu J, Rascovsky K, Cosentino S, Grossman M, Elman L, Benatar M (2022) Defining cognitive impairment in amyotrophic lateral sclerosis: an evaluation of empirical approaches. Amyotroph Lateral Scler Frontotemporal Degener 1&#x2013;10.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>